Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Alveolar Bone Atrophy

cetylpyridinium chloride anhydrous has been researched along with Alveolar Bone Atrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyrelles, SS; Pereira, RB; Stefanon, I; Vasquez, EC1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Alveolar Bone Atrophy

ArticleYear
Oral P. gingivalis infection alters the vascular reactivity in healthy and spontaneously atherosclerotic mice.
    Lipids in health and disease, 2011, May-17, Volume: 10

    Topics: Acetylcholine; Alveolar Bone Loss; Animals; Apolipoproteins E; Arterioles; Atherosclerosis; Bacteroidaceae Infections; Blood Vessels; Body Weight; Cholesterol; Dose-Response Relationship, Drug; Health; Inflammation; Male; Mice; Mice, Inbred C57BL; Mouth; Nitroprusside; Phenylephrine; Porphyromonas gingivalis

2011